Autism spectrum disorders (ASDs) are diagnosed in 1/100 children worldwide, based on two
core symptoms: deficits in social interaction and communication, and stereotyped …

Autism spectrum disorder (ASD) refers to a complicated range of childhood
neurodevelopmental disorders which can occur via genetic or non-genetic factors. Clinically …

Abstract Autism Spectrum Disorder (ASD) is one of the most common neurodevelopmental
disorders with no drugs treating the core symptoms and no validated biomarkers for clinical …

In 2017, facing lack of progress and failures encountered in targeted drug development for
Autism Spectrum Disorder (ASD) and related neurodevelopmental disorders, the ISCTM …

Oxytocin has been suggested as a potential therapeutic agent in autism and other
neuropsychiatric conditions. Although, the link between the deficit in “SH3 domain and …

Drug addiction is one of the leading causes of mortality worldwide. Despite great advances
were achieved in understanding the neurobiology of drug addiction, the therapeutic options …

Recent years have seen an impressive amount of research devoted to understanding the
etiopathology of Autism Spectrum Disorder (ASD) and developing therapies for this …

Intellectual disability (ID) and autism spectrum disorder (ASD) are neurodevelopmental
disorders that have become a primary clinical and social concern, with a prevalence of 2 …

The membrane‐associated mucin (MAM) domain containing glycosylphosphatidylinositol
anchor 2 protein single knock‐out mice (MDGA2+/−) are models of ASD. We examined the …

In the study of transgenic mouse models of neurodevelopmental and neurodegenerative
disorders, we use batteries of tests to measure deficits in behaviour and from the results of …